Document is current

Any future updates will be listed below

CRISPR-Cas9-based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: a cross-talk between FGF21 and the NRF2 pathway

Crossref DOI link: https://doi.org/10.1007/s11427-021-2067-7

Published Online: 2022-04-01

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark